Aethlon Medical Expands Highly Dilutive ATM Program, May Sell $542K More Shares
AEMD sits 51% above its 52-week low of $1.36.
Summary
Aethlon Medical is expanding its existing At-The-Market (ATM) offering, allowing it to sell up to an additional $542,716 in common stock, adding to the $1.85 million already sold under the program, to address its "going concern" warning.
Key Events · Financing and Capital Events · AEMD
-
Expanded ATM Offering
The company filed an amendment to its At-The-Market (ATM) prospectus, authorizing the sale of up to an additional $542,716 in common stock.
-
Significant Prior Sales
This new authorization follows the sale of $1,849,457 worth of securities under the same ATM program prior to this amendment.
-
High Dilution
The total amount raised and authorized for sale under this ATM program ($2.39 million) represents approximately 72.6% of the company's current market capitalization.
-
Going Concern Context
This capital raise is critical for the company, which previously issued a "going concern" warning due to insufficient cash for the next 12 months.
Analysis · AEMD · Industrial Applications And Services
Aethlon Medical, facing a "going concern" warning, has updated its At-The-Market (ATM) offering program, authorizing the sale of up to an additional $542,716 in common stock. This follows prior sales of $1.85 million under the same program. The combined potential and actual sales represent a significant portion of the company's current market capitalization, indicating substantial dilution for existing shareholders as the company seeks to extend its cash runway. The offering price for the public float calculation ($3.07) is significantly higher than the current stock price ($2.05), suggesting that future sales will be at a lower price, increasing the dilutive impact.
How filings like this one have moved
In the 30 days to Sep 18, 2026, 35.4% of the 1144 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.40%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, AEMD was trading at $2.05 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.3M. The 52-week trading range was $1.36 to $29.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.